Abstract:Background: Missed abortion (MA) is an asymptomatic embryo death during the early stage of pregnancy affecting 10 to 15% pregnancies worldwide. The lack of prompt diagnostic biomarkers of MA poses a great challenge for current clinical implementation. While the diversified adaptation in hormonal signatures determines outcomes of pregnancy, whether it affects the onset of MA is under-investigated.Methods: 78 subjects with MA and 86 controls of pregnancies of normal births matching on maternal age and body mass index (BMI), who attended their first prenatal care during gestational age (6-12 weeks), were nested from a prospective cohort to investigate the association between MA and quantified levels of metabolic-related hormones.Findings: We found the serum fibroblast growth factor 21 (FGF21) and fatty acid-binding protein-4 (FABP4) were significantly and independently elevated in patients with MA compared to the controls. Compared to FABP4, a single measurement of FGF21 level effectively discriminate case of MA from pregnancies of normal births (an area under operating characteristic’s curve (AUROC): 0.81, 95% CI 0.76-0.92). The clinical cutoff of serum FGF21 to identify subjects with MA was determined as 98.73 pg/ml. Association between outcome of MA and serum FGF21 was further evaluated in an external validation cohort consisted of subjects with MA ( n =34) and induced abortion (IA, n =27), yielding a sensitivity of 94.1% (80.9 – 98.9), specificity of 70.4% (51.5 – 84.2), and AUROC of 0.85 (95% CI 0.75-0.96). Meanwhile, the placenta of MA group was characterized by impaired FGF21 signaling aligned with attenuated angiogenesis and villi dysplasia compared to IA group.Interpretation: The study reveals serum levels of FGF21 may serve as a potential biomarker for the early recognition of MA.Funding Statement: This study was supported by grants from the Subject Innovation Team of Shannxi University of Chinese Medicine (2019-YS02), NSFC Grant (No. 81770849) and grants of Key Research Program in Department of Education of Guangdong Province (2016KZDXM041).Declaration of Interests: The authors declared no conflict of interest.Ethics Approval Statement: Ethical approvals of this study protocol were granted by the Human Research Ethics Committee for Clinical Study of Second Affiliated Hospital of Shaanxi University of Chinese Medicine (IRB Ref. No.: KY201913). All clinical studies were conducted according to Declaration of Helsinki principles. The written informed consent was obtained from all participants before inclusion in this study.

Fibroblast Growth Factor 21 is a Potent Blood-Based Biomarker for the Missed Abortion in Humans

Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humans

High Circulating Fibroblast Growth Factor-21 Levels as a Prognostic Marker in Fatty Pancreas Patients

Expression of leukemia inhibitory factor in the chorionic villi of spontaneous abortion

High circulating fibroblast growth factor-21 levels as a screening marker in fatty pancreas patients

Using liquid chromatography and mass spectrometry to predict potential biomarkers for missed miscarriage and its metabolic pathways in a tertiary center: A cross‐sectional analytic study

Comprehensive Analysis of the Differential Expression Profile of Micrornas in Missed Abortion

Analysis of clinical characteristics and genetic testing in patients with acute fatty liver of pregnancy: a retrospective study

Fibroblast Growth Factor 21 Expressions in White Blood Cells and Sera of Patients with Gestational Diabetes Mellitus During Gestation and Postpartum

Contribution of Serum FGF21 Level to the Identification of Left Ventricular Systolic Dysfunction and Cardiac Death

Imbalance of the Gut Microbiota May Be Associated with Missed Abortions: A Perspective Study from a General Hospital of Hunan Province

Correlation of Maternal Plasma Total Cell-Free DNA and Fetal DNA Levels with Short Term Outcome of First-Trimester Vaginal Bleeding.

Novel High-Coverage Targeted Metabolomics Method (swathtomrm) for Exploring Follicular Fluid Metabolome Alterations in Women with Recurrent Spontaneous Abortion Undergoing in Vitro Fertilization

Missed abortion in the 11–21-week period: Fetal autopsy and placental histopathological analysis of 794 cases

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells And Cytokines Interact With Estradiol In Cases Of Missed Abortion

Distinct Mrna and Long Non‐coding RNA Expression Profiles of Decidual Natural Killer Cells in Patients with Early Missed Abortion

Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.

The Expression and Significance of HIF-1α,VEGF, VEGFR-1 and VEGFR-2 in Missed Abortion Patients

Maternal Fibroblast Growth Factor 21 Levels Decrease during Early Pregnancy in Normotensive Pregnant Women but Are Higher in Preeclamptic Women-A Longitudinal Study

Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study

Expression of FSTL1 in serum, villi and deciduas in women with unexplained missed abortion